Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Duke University

ClinicalTrials.gov Identifier:

NCT00003462

First received: November 1, 1999

Last updated: February 15, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2001
Primary Completion Date:	February 2001 (Final data collection date for primary outcome measure)